COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations. La presente invención se r...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
La presente invención se refiere en general a compuestos antivirales, y más específicamente se dirige a combinaciones de compuestos los cuales pueden inhibir el virus de la Hepatitis C (HCV), composiciones que comprenden tales compuestos, y métodos para tratar la Hepatitis C usando tales combinaciones. |
---|